Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins

Experimental Cell Research

Volumn 283, Issue 2, 2003, Pages 184-195

  Meissner, Michael ^a   Lopato, Sergiy ^b,c   Gotzmann, Josef ^a   Sauermann, Georg ^a   Barta, Andrea ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; ONCOPROTEIN; PROTEIN; PROTEIN SC35; PROTEIN SR; PROTEIN SRM160; PROTEIN SRP75; PROTO ONCOPROTEIN TLS FUS; RECOMBINANT PROTEIN; SPLICING FACTOR PTB; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS MATRIX; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA SPLICING; SPLICEOSOME;

EID: 0344407006     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00046-0     Document Type: Article

References (59)

1. Nickerson J.A., Krockmalnic G., Wan K.M., Penman S. The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus. Proc. Natl. Acad. Sci. USA. 94:1997;4446-4450.
2. Hendzel M.J., Boisvert F., Bazett Jones D.P. Direct visualization of a protein nuclear architecture. Mol. Biol. Cell. 10:1999;2051-2062.
3. Berezney R., Coffey D.S. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun. 60:1974;1410-1417.
4. Berezney R., Mortillaro M.J., Ma H., Wei X., Samarabandu J. The nuclear matrix a structural milieu for genomic function . Int. Rev. Cytol. 65:1995;162-165.
5. Stein G.S., Stein J.L., Lian J.B., van Wijnen A.J., Montecino M. Functional interrelationships between nuclear structure and transcriptional control contributions to regulation of cell cycle- and tissue-specific gene expression . J. Cell. Biochem. 62:1996;198-209.
6. Goldberg M., Harel A., Gruenbaum Y. The nuclear lamina molecular organization and interaction with chromatin . Crit. Rev. Eukaryot. Gene. Expression. 9:1999;285-293.
7. Harborth J., Wang J., Gueth Hallonet C., Weber K., Osborn M. Self assembly of NuMA multiarm oligomers as structural units of a nuclear lattice . EMBO J. 18:1999;1689-1700.
8. Fey E.G., Krochmalnic G., Penman S. The nonchromatin substructures of the nucleus the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy . J. Cell Biol. 102:1986;1654-1665.
9. Wei X., Somanathan S., Samarabandu J., Berezney R. Three-dimensional visualization of transcription sites and their association with splicing factor-rich nuclear speckles. J. Cell Biol. 146:1999;543-558.
10. Misteli T., Spector D.L. The cellular organization of gene expression. Curr. Opin. Cell Biol. 10:1998;323-331.
11. Zeng C., Kim E., Warren S.L., Berget S.M. Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity. EMBO J. 16:1997;1401-1412.
12. Burge C.B., Tuschl T., Sharp P.A. Splicing of Precursors to mRNAs by the Spliceosomes. second ed. 1999;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:1996;367-409.
14. Blencowe B.J., Bowman J.A., McCracken S., Rosonina E. SR-related proteins and the processing of messenger RNA precursors. Biochem. Cell Biol. 77:1999;277-291.
15. Zahler A.M., Neugebauer K.M., Lane W.S., Roth M.B. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science. 260:1993;219-222.
16. Fu X.-D. The superfamily of arginine/serine-rich splicing factors. RNA. 1:1995;663-680.
17. Tacke R., Manley J.L. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11:1999;358-362.
18. Blencowe B.J., Issner R., Nickerson J.A., Sharp P.A. A coactivator of pre-mRNA splicing. Genes Dev. 12:(7):1998;996-1009.
19. Eldridge A.G., Li Y., Sharp P.A., Blencowe B.J. The SRm160/300 splicing coactivator is required for exon-enhancer function. Proc. Natl. Acad. Sci. USA. 96:1999;6125-6130.
20. Immanuel D., Zinszner H., Ron D. Association of SARFH (sarcoma- associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell. Biol. 15:1995;4562-4571.
21. Yang L., Embree L.J., Tsai S., Hickstein D.D. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273:1998;27761-27764.
22. Rabbitts T.H., Forster A., Larson R., Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet. 4:1993;175-180.
23. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 363:1993;640-644.
24. Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 110:1997;1741-1750.
25. Hackl W., Fischer U., Luhrmann R. A 69-kD protein that associates reversibly with the Sm core domain of several spliceosomal snRNP species. J. Cell Biol. 124:1994;261-272.
26. Morohoshi F., Arai K., Takahashi E.I., Tanigami A., Ohki M. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins. Genomics. 38:1996;51-57.
27. Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N., Ohki M. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene. 221:1998;191-198.
28. Bertolotti A., Lutz Y., Heard D.J., Chambon P., Tora L. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15:1996;5022-5031.
29. Calvio C., Neubauer G., Mann M., Lamond A.I. Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. RNA. 1:1995;724-733.
30. Zinszner H., Albalat R., Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8:1994;2513-2526.
31. Zhang W.J., Wu J.Y. Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing. Mol. Cell. Biol. 18:1998;676-684.
32. Yang L., Embree L.J., Hickstein D.D. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol. Cell. Biol. 20:2000;3345-3354.
33. Bertrand P., Akhmedov A.T., Delacote F., Durrbach A., Lopez B.S. Human POMp75 is identified as the pro-oncoprotein TLS/FUS both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation . Oncogene. 18:1999;4515-4521.
34. Kuroda M., Sok J., Webb L., Baechtold H., Urano F., Yin Y., Chung P., Rooij D.G., Akhmedov A., Ashley T., Ron D. Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J. 19:2000;453-462.
35. Hicks G.G., Singh N., Nashabi A., Mai S., Bozek G., Klewes L., Arapovic D., White E.K., Koury M.J., Oltz E.M., Van Kaer L., Ruley H.E. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nature Genet. 24:2000;175-179.
36. Holzmann K., Korosec T., Gerner C., Grimm R., Sauermann G. Identification of human common nuclear-matrix proteins as heterogeneous nuclear ribonucleoproteins H and H′ by sequencing and mass spectrometry. Eur. J. Biochem. 244:1997;479-486.
37. Harlow C., Lane D. Antibodies-A Laboratory Manual. 1988;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Olmsted, J.B. Analysis of cytoskeletal structures using blot-purified monospecific antibodies. Methods Enzymol. (1986) 134467-134472.
39. Gerner C., Holzmann K., Grimm R., Sauermann G. Similarity between nuclear matrix proteins of various cells revealed by an improved isolation method. J. Cell. Biochem. 71:1998;363-374.
40. Mayeda A., Helfman D.M., Krainer A.R. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF [published erratum appears in Mol. Cell. Biol. 13 (1993) 4458]. Mol. Cell. Biol. 13:1993;2993-3001.
41. Hochstrasser D.F., Harrington M.G., Hochstrasser A.C., Miller M.J., Merril C.R. Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal. Biochem. 173:1988;424-435.
42. Meissner M., Dechat T., Gerner C., Grimm R., Foisner R., Sauermann G. Differential nuclear localization and nuclear matrix association of the splicing factors PSF and PTB. J. Cell. Biochem. 76:2000;559-566.
43. Gotzmann J., Eger A., Meissner M., Grimm R., Gerner C., Sauermann G., Foisner R. Two-dimensional electrophoresis reveals a nuclear matrix-associated nucleolin complex of basic isoelectric point. Electrophoresis. 18:1997;2645-2653.
44. Gotzmann J., Gerner C. A method to produce Ponceau replicas from blots application for Western analysis . Electrophoresis. 21:2000;523-525.
45. Krainer A.R., Maniatis T., Ruskin B., Green M.R. Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell. 36:1984;993-1005.
46. Werneke J.M., Ogren W.L. Structure of an Arabidopsis thaliana cDNA encoding rubisco activase. Nucleic Acids Res. 17:1989;2871.
47. Misteli T., Caceres J.F., Clement J.Q., Krainer A.R., Wilkinson M.F., Spector D.L. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell Biol. 143:(2):1998;297-307.
48. Gerner C., Sauermann G. Nuclear matrix proteins specific for subtypes of human hematopoietic cells. J. Cell. Biochem. 72:1999;470-482.
49. Korosec T., Gerner C., Sauermann G. Common nuclear matrix proteins in rat tissues. Electrophoresis. 18:1997;2109-2115.
50. Aman P., Panagopoulos I., Lassen C., Fioretos T., Mencinger M., Toresson H., Hoglund M., Forster A., Rabbitts T.H., Ron D., Mandahl N., Mitelman F. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics. 37:1996;1-8.
51. Patton J.G., Mayer S.A., Tempst P., Nadal Ginard B. Characterization and molecular cloning of polypyrimidine tract-binding protein a component of a complex necessary for pre-mRNA splicing . Genes Dev. 5:1991;1237-1251.
52. Roth M.B., Zahler A.M., Stolk J.A. A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J. Cell Biol. 115:1991;587-596.
53. Blencowe B.J., Nickerson J.A., Issner R., Penman S., Sharp P.A. Association of nuclear matrix antigens with exon-containing splicing complexes. J. Cell Biol. 127:1994;593-607.
54. Huang S., Spector D.L. Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev. 5:1991;2288-2302.
55. Fu X.D., Mayeda A., Maniatis T., Krainer A.R. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl. Acad. Sci. USA. 89:1992;11224-11228.
56. Wu S., Green M.R. Identification of a human protein that recognizes the 3′ splice site during the second step of pre-mRNA splicing. EMBO J. 16:1997;4421-4432.
57. Hallier M., Lerga A., Barnache S., Tavitian A., Moreau Gachelin F. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 273:1998;4838-4842.
58. Bertolotti A., Melot T., Acker J., Vigneron M., Delattre O., Tora L. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes . Mol. Cell. Biol. 18:1998;1489-1497.
59. Petermann R., Mossier B.M., Aryee D.N., Khazak V., Golemis E.A., Kovar H. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene. 17:1998;603-610.